184 related articles for article (PubMed ID: 38907188)
1. Advancements in understanding the role of intestinal dysbacteriosis mediated mucosal immunity in IgA nephropathy.
Fan Y; Wang Y; Xiao H; Sun H
BMC Nephrol; 2024 Jun; 25(1):203. PubMed ID: 38907188
[TBL] [Abstract][Full Text] [Related]
2. Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies.
He JW; Zhou XJ; Lv JC; Zhang H
Theranostics; 2020; 10(25):11462-11478. PubMed ID: 33052226
[TBL] [Abstract][Full Text] [Related]
3. High levels of gut-homing immunoglobulin A+ B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients.
Sallustio F; Curci C; Chaoul N; Fontò G; Lauriero G; Picerno A; Divella C; Di Leo V; De Angelis M; Ben Mkaddem S; Macchia L; Gallone A; Monteiro RC; Pesce F; Gesualdo L
Nephrol Dial Transplant; 2021 Feb; 36(3):452-464. PubMed ID: 33200215
[TBL] [Abstract][Full Text] [Related]
4. The Gut-Renal Connection in IgA Nephropathy.
Coppo R
Semin Nephrol; 2018 Sep; 38(5):504-512. PubMed ID: 30177022
[TBL] [Abstract][Full Text] [Related]
5. Aberrant Gut Microbiome Contributes to Barrier Dysfunction, Inflammation, and Local Immune Responses in IgA Nephropathy.
Tang Y; Xiao Y; He H; Zhu Y; Sun W; Hu P; Xu X; Liu Z; Yan Z; Wei M
Kidney Blood Press Res; 2023; 48(1):261-276. PubMed ID: 36878203
[TBL] [Abstract][Full Text] [Related]
6. Pathogenetic and Therapeutic Role of Gut Microbiome in Immunoglobin A Nephropathy.
Li HB; Zhou JL; Xie PP; Feng YT; Chen Y; Zhang DF; Wang DG; Pan HF
Curr Pharm Des; 2023; 29(6):468-473. PubMed ID: 36825697
[TBL] [Abstract][Full Text] [Related]
7. The gut microbiota posttranslationally modifies IgA1 in autoimmune glomerulonephritis.
Gleeson PJ; Benech N; Chemouny J; Metallinou E; Berthelot L; da Silva J; Bex-Coudrat J; Boedec E; Canesi F; Bounaix C; Morelle W; Moya-Nilges M; Kenny J; O'Mahony L; Saveanu L; Arnulf B; Sannier A; Daugas E; Vrtovsnik F; Lepage P; Sokol H; Monteiro RC
Sci Transl Med; 2024 Mar; 16(740):eadl6149. PubMed ID: 38536935
[TBL] [Abstract][Full Text] [Related]
8. Role of gut microbiome in ankylosing spondylitis: an analysis of studies in literature.
Xu YY; Tan X; He YT; Zhou YY; He XH; Huang RY
Discov Med; 2016 Dec; 22(123):361-370. PubMed ID: 28147218
[TBL] [Abstract][Full Text] [Related]
9. Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population.
Zhong Z; Tan J; Tan L; Tang Y; Qiu Z; Pei G; Qin W
Int Immunopharmacol; 2020 Dec; 89(Pt B):107085. PubMed ID: 33068859
[TBL] [Abstract][Full Text] [Related]
10. Spinal cord injury and the human microbiome: beyond the brain-gut axis.
Wallace DJ; Sayre NL; Patterson TT; Nicholson SE; Hilton D; Grandhi R
Neurosurg Focus; 2019 Mar; 46(3):E11. PubMed ID: 30835680
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiome Homeostasis and the CD4 T- Follicular Helper Cell IgA Axis in Human Immunodeficiency Virus Infection.
Onabajo OO; Mattapallil JJ
Front Immunol; 2021; 12():657679. PubMed ID: 33815419
[TBL] [Abstract][Full Text] [Related]
12. The Gut and Kidney Crosstalk in Immunoglobulin A Nephropathy.
Sanchez-Russo L; Rajasekaran A; Bin S; Faith J; Cravedi P
Kidney360; 2022 Sep; 3(9):1630-1639. PubMed ID: 36245664
[TBL] [Abstract][Full Text] [Related]
13. Role of gut-kidney axis in renal diseases and IgA nephropathy.
Monteiro RC; Berthelot L
Curr Opin Gastroenterol; 2021 Nov; 37(6):565-571. PubMed ID: 34482323
[TBL] [Abstract][Full Text] [Related]
14. The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease.
Chi M; Ma K; Wang J; Ding Z; Li Y; Zhu S; Liang X; Zhang Q; Song L; Liu C
J Immunol Res; 2021; 2021():5516035. PubMed ID: 34095319
[TBL] [Abstract][Full Text] [Related]
15. The Gut and Blood Microbiome in IgA Nephropathy and Healthy Controls.
Shah NB; Nigwekar SU; Kalim S; Lelouvier B; Servant F; Dalal M; Krinsky S; Fasano A; Tolkoff-Rubin N; Allegretti AS
Kidney360; 2021 Aug; 2(8):1261-1274. PubMed ID: 35369657
[TBL] [Abstract][Full Text] [Related]
16. Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
Moldoveanu Z; Suzuki H; Reily C; Satake K; Novak L; Xu N; Huang ZQ; Knoppova B; Khan A; Hall S; Yanagawa H; Brown R; Winstead CJ; O'Quinn DB; Weinmann A; Gharavi AG; Kiryluk K; Julian BA; Weaver CT; Suzuki Y; Novak J
J Autoimmun; 2021 Mar; 118():102593. PubMed ID: 33508637
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the microbiota by oral antibiotics treats immunoglobulin A nephropathy in humanized mice.
Chemouny JM; Gleeson PJ; Abbad L; Lauriero G; Boedec E; Le Roux K; Monot C; Bredel M; Bex-Coudrat J; Sannier A; Daugas E; Vrtovsnik F; Gesualdo L; Leclerc M; Berthelot L; Ben Mkaddem S; Lepage P; Monteiro RC
Nephrol Dial Transplant; 2019 Jul; 34(7):1135-1144. PubMed ID: 30462346
[TBL] [Abstract][Full Text] [Related]
18. The microbiome and IgA nephropathy.
Haniuda K; Gommerman JL; Reich HN
Semin Immunopathol; 2021 Oct; 43(5):649-656. PubMed ID: 34664087
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.
Shah A; Macdonald GA; Morrison M; Holtmann G
Am J Gastroenterol; 2020 Jun; 115(6):814-822. PubMed ID: 32250997
[TBL] [Abstract][Full Text] [Related]
20. Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?
Monteiro RC; Rafeh D; Gleeson PJ
Microorganisms; 2022 Mar; 10(4):. PubMed ID: 35456735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
